Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMustang Bio Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$140.00 | -$140.00 | -$140.00 |
| Q2 2026 | 1 | -$140.00 | -$140.00 | -$140.00 |
| Q3 2026 | 1 | -$145.50 | -$145.50 | -$145.50 |
| Q4 2026 | 1 | -$135.20 | -$135.20 | -$135.20 |
| Q1 2027 | 1 | -$144.00 | -$144.00 | -$144.00 |
| Q2 2027 | 1 | -$138.00 | -$138.00 | -$138.00 |
| Q3 2027 | 1 | -$156.00 | -$156.00 | -$156.00 |
| Q4 2027 | 1 | -$148.13 | -$148.13 | -$148.13 |
| Q1 2028 | 1 | -$142.50 | -$142.50 | -$142.50 |
| Q2 2028 | 1 | -$150.50 | -$150.50 | -$150.50 |
| Q3 2028 | 1 | -$90.38 | -$90.38 | -$90.38 |
| Q4 2028 | 1 | -$63.75 | -$63.75 | -$63.75 |
| Q1 2029 | 1 | -$77.83 | -$77.83 | -$77.83 |
| Q2 2029 | 1 | -$43.50 | -$43.50 | -$43.50 |
| Q3 2029 | 1 | -$7.00 | -$7.00 | -$7.00 |
| Q4 2029 | 1 | -$6.50 | -$6.50 | -$6.50 |
| Q1 2030 | 1 | -$5.50 | -$5.50 | -$5.50 |
Mustang Bio Inc Earnings Date And Information
Mustang Bio Inc last posted its earnings results on Tuesday, May 5th, 2026. The company reported $-0.14 earnings per share for the quarter, topping analysts' consensus estimates of $-140 by $139.86. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Mustang Bio Inc has generated $0 earnings per share over the last year ($-0.39 diluted earnings per share) and currently has a price-to-earnings ratio of -1.61. Mustang Bio Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Mustang Bio Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/05/2026 | Q1 2026 | -$140.00 | -$0.14 | 139.86 | $0 | $0 |
| 03/19/2026 | Q4 2025 | -$5.50 | -$0.07 | 5.43 | N/A | $0 |
| 11/07/2025 | Q3 2025 | N/A | -$0.08 | N/A | N/A | $0 |
| 08/08/2025 | Q2 2025 | N/A | -$0.13 | N/A | N/A | $0 |
| 05/14/2025 | Q1 2025 | N/A | -$0.05 | N/A | N/A | $0 |
| 03/28/2025 | Q4 2024 | N/A | -$0.95 | N/A | N/A | $0 |
| 11/08/2024 | Q3 2024 | -$6.50 | -$0.16 | 6.34 | N/A | $0 |
| 08/13/2024 | Q2 2024 | -$7.00 | -$0.94 | 6.06 | N/A | $0 |
| 05/15/2024 | Q1 2024 | -$0.87 | -$0.46 | 0.41 | N/A | $0 |
| 03/11/2024 | Q4 2023 | -$84.00 | -$0.93 | 83.07 | N/A | $0 |
| 11/14/2023 | Q3 2023 | -$94.00 | -$1.23 | 92.77 | N/A | $0 |
| 08/14/2023 | Q2 2023 | -$103.50 | -$2.00 | 101.5 | N/A | $0 |
| 05/12/2023 | Q1 2023 | -$142.50 | -$2.25 | 140.25 | N/A | $0 |
| 03/29/2023 | Q4 2022 | N/A | -$2.91 | N/A | N/A | $0 |
| 11/14/2022 | Q3 2022 | -$149.93 | -$2.42 | 147.51 | N/A | $0 |
| 08/11/2022 | Q2 2022 | -$157.42 | -$2.50 | 154.92 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$134.93 | -$3.06 | 131.87 | N/A | $0 |
| 03/23/2022 | Q4 2021 | -$157.42 | -$3.42 | 154 | N/A | $0 |
| 11/12/2021 | Q3 2021 | -$134.93 | -$2.80 | 132.13 | N/A | $0 |
| 08/16/2021 | Q2 2021 | -$149.93 | -$2.46 | 147.47 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Mustang Bio Inc Earnings: FAQ's
In the previous quarter, Mustang Bio Inc (:MBIO) reported $-0.14 earnings per share (EPS) to beat the analysts' consensus estimate of $-140 by $139.86.
The conference call for Mustang Bio Inc's latest earnings report can be listened to online.
The conference call transcript for Mustang Bio Inc's latest earnings report can be read online.
Mustang Bio Inc (:MBIO) has a recorded net income of $-1,921,000.Mustang Bio Inc has generated $-0.39 earnings per share over the last four quarters.
Mustang Bio Inc (:MBIO) has a price-to-earnings ratio of -1.61 and price/earnings-to-growth ratio is -0.02.